IN2013MN01394A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MN01394A IN2013MN01394A IN1394MUN2013A IN2013MN01394A IN 2013MN01394 A IN2013MN01394 A IN 2013MN01394A IN 1394MUN2013 A IN1394MUN2013 A IN 1394MUN2013A IN 2013MN01394 A IN2013MN01394 A IN 2013MN01394A
- Authority
- IN
- India
- Prior art keywords
- alphabodies
- polypeptides
- nucleic acids
- host cells
- compositions
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 5
- 102000039446 nucleic acids Human genes 0.000 abstract 3
- 108020004707 nucleic acids Proteins 0.000 abstract 3
- 150000007523 nucleic acids Chemical class 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 239000003102 growth factor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2318/00—Antibody mimetics or scaffolds
- C07K2318/20—Antigen-binding scaffold molecules wherein the scaffold is not an immunoglobulin variable region or antibody mimetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- AIDS & HIV (AREA)
- Transplantation (AREA)
- Urology & Nephrology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2011050138 | 2011-01-06 | ||
| PCT/EP2012/050193 WO2012093172A1 (en) | 2011-01-06 | 2012-01-06 | Alphabodies specifically binding to cytokines or growth factors and/or cytokine or growth factor receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MN01394A true IN2013MN01394A (ro) | 2015-06-12 |
Family
ID=44242740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1394MUN2013 IN2013MN01394A (ro) | 2011-01-06 | 2012-01-06 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20140057830A1 (ro) |
| JP (1) | JP2014504869A (ro) |
| CN (1) | CN103339148A (ro) |
| AU (1) | AU2012204846B2 (ro) |
| BR (1) | BR112013017367A2 (ro) |
| CA (1) | CA2821646A1 (ro) |
| DK (1) | DK2661447T3 (ro) |
| IN (1) | IN2013MN01394A (ro) |
| WO (1) | WO2012093172A1 (ro) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2668210T3 (da) | 2011-01-26 | 2020-08-24 | Celldex Therapeutics Inc | Anti-kit antistoffer og anvendelser deraf |
| IN2014MN01562A (ro) | 2012-01-06 | 2015-05-08 | Complix Nv | |
| DK3381943T3 (da) | 2012-07-25 | 2022-05-16 | Celldex Therapeutics Inc | Anti-kit-antistoffer og anvendelser deraf |
| US10023647B2 (en) | 2012-10-22 | 2018-07-17 | Complix Nv | Polypeptides capable of cellular internalization |
| WO2014064080A1 (en) | 2012-10-22 | 2014-05-01 | Complix Nv | Polypeptides specifically binding to il-23 |
| US10239943B2 (en) | 2014-05-23 | 2019-03-26 | Celldex Therapeutics, Inc. | Treatment of eosinophil or mast cell related disorders |
| WO2017102835A1 (en) * | 2015-12-14 | 2017-06-22 | Complix Nv | Binding molecule comprising an alphabody-polypeptide and an antibody |
| TW202221039A (zh) | 2020-10-19 | 2022-06-01 | 美商碩騰服務公司 | 犬及貓抑瘤素Ｍ受體β之抗體及其用途 |
| CN113315431B (zh) * | 2021-04-22 | 2023-07-28 | 湖南工业大学 | 基于等价输入干扰系统的pmsm失磁故障控制方法、电机 |
| CN114544812B (zh) * | 2022-02-18 | 2023-06-30 | 复旦大学附属中山医院 | 一种代谢组合式标志物在诊断哮喘中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101323643B (zh) * | 2007-06-15 | 2010-12-01 | 烟台荣昌生物工程有限公司 | 优化的TACI-Fc融合蛋白 |
| EP2161278B1 (en) | 2008-09-08 | 2012-05-23 | Complix N.V. | Single-chain coiled coil scaffold |
| WO2010066740A1 (en) * | 2008-12-08 | 2010-06-17 | Complix Nv | Single-chain antiparallel coiled coil proteins |
| WO2012092970A1 (en) * | 2011-01-06 | 2012-07-12 | Complix Nv | Alphabody libraries and methods for producing the same |
-
2012
- 2012-01-06 JP JP2013547867A patent/JP2014504869A/ja active Pending
- 2012-01-06 AU AU2012204846A patent/AU2012204846B2/en not_active Ceased
- 2012-01-06 BR BR112013017367A patent/BR112013017367A2/pt not_active IP Right Cessation
- 2012-01-06 WO PCT/EP2012/050193 patent/WO2012093172A1/en active Application Filing
- 2012-01-06 CA CA2821646A patent/CA2821646A1/en not_active Abandoned
- 2012-01-06 US US13/994,107 patent/US20140057830A1/en not_active Abandoned
- 2012-01-06 CN CN2012800046860A patent/CN103339148A/zh active Pending
- 2012-01-06 DK DK12702771.2T patent/DK2661447T3/en active
- 2012-01-06 IN IN1394MUN2013 patent/IN2013MN01394A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012204846B2 (en) | 2016-09-08 |
| WO2012093172A1 (en) | 2012-07-12 |
| AU2012204846A1 (en) | 2013-07-04 |
| BR112013017367A2 (pt) | 2016-11-22 |
| DK2661447T3 (en) | 2015-11-02 |
| US20140057830A1 (en) | 2014-02-27 |
| CA2821646A1 (en) | 2012-07-12 |
| CN103339148A (zh) | 2013-10-02 |
| JP2014504869A (ja) | 2014-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2013MN01394A (ro) | ||
| EA201290567A1 (ru) | Получение гетерологичных полипептидов в микроводорослях, внеклеточные микроводорослевые тельца, композиции и способы их получения и применения | |
| ZA201405021B (en) | Cx3cr1-binding polypeptides | |
| PH12019500441A1 (en) | Monoclonal antibodies against tissue factor pathway inhibitor (tfpi) | |
| CA2851316C (en) | Genes and proteins for alkanoyl-coa synthesis | |
| TN2014000438A1 (en) | Anti-fcrn antibodies | |
| IN2014MN01562A (ro) | ||
| PH12012501838A1 (en) | Aptamers to ã-ngf and their use in treating ã-ngf mediated diseases and disorders | |
| ZA201400490B (en) | Arginine- free tnfr: fc- fusion polypeptide compositions and methods of use | |
| MX2015007921A (es) | Compuestos heterociclicos novedosos como inhibidores de bromodominio. | |
| TN2012000512A1 (en) | Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies | |
| MY162737A (en) | 4-1bb binding molecules | |
| HK1255729A1 (zh) | 包含針對pcsk9的人抗體的藥物組合物 | |
| SG194469A1 (en) | Tetrahydroquinoline derivatives useful as bromodomain inhibitors | |
| MX2013003681A (es) | Ácidos nucleicos manipulados y métodos de uso de los mismos. | |
| IN2015DN03322A (ro) | ||
| TN2012000511A1 (en) | Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies | |
| PH12014501970A1 (en) | Antibodies to bradykinin b1 receptor ligands | |
| MX347734B (es) | Anticuerpos anti-s100a4 y usos aplicaciones terapéuticas. | |
| EP2744480B8 (en) | Low protein percentage gelling compositions | |
| AU2011301714B2 (en) | Synthetic gene for expressing Sm-14 in Pichia pastoris, methods for producing and purifying Sm-14 and the use thereof as a vaccine and diagnostic medium | |
| TN2014000395A1 (en) | Antibodies to bradykinin b1 receptor ligands |